The increasing problem of infectious diseases caused by antibiotic-resistant bacteria has 25 intensified a search for novel host-directed therapies aimed at either boosting immune-mediated 26 bacterial control or reducing immunopathology. Macrophages play central roles in eliminating 27 pathogens as well as in tissue homeostasis and repair via alternative activation programs, M1-28 like and M2-like, respectively. Macrophages of both phenotypes are often present at the sites of 29 chronic unresolved inflammation, such infectious granulomas and solid tumors, where the M2-30 like macrophages generate microenvironment conducive for pathogen survival or tumor 31 progression.
Introduction

149
To further investigate the dynamics of translation inhibition by CMLD010536 in BMDM, 150 we used a puromycin incorporation assay. Puromycin incorporation during a one-hour pulse 151 was determined after 2 -24 h of rocaglate treatment by western blot using puromycin-specific 152 antibodies. The rocaglate treatment significantly reduced translation rates at all timepoints in a 153 dose-dependent manner ( Fig.2A) . However, the levels of ongoing translation were similar at all 154 of the timepoints demonstrating that translation inhibition was partial and sustained over the 155 time course of the rocaglate treatment. To identify proteins expressed in BMDMs after 24 h of 156 treatment with 100 nM of CMLD010536, we performed proteomic analysis using mass 157 spectrometry (Supplemental Table 2 ). The abundance of Sequestosome 1 (SQSTM1 aka p62) 158 protein was found to significantly increase. We confirmed the induction of p62 protein and 159 mRNA (Figs.2B&C), demonstrating that treatment of BMDM with the rocaglate induced de novo 160 p62 protein synthesis.
161
The SQSTM1/p62 protein plays an important role in stress resilience by controlling 162 selective autophagy and anti-oxidant defense gene expression (24-33). Its expression can be 163 induced by various stressors. Our previous analysis of CMLD010536-activated pathways using 164 gene expression profiling suggested activation of stress kinase-mediated pathways (16) .
165
Therefore, we tested whether the p62 induction by CMLD010536 is mediated by stress- Next, we compared the kinetics of p38 phosphorylation ( Fig.2E ) and p62 mRNA 173 upregulation (Fig.2F ) during the course of the rocaglate treatment. We observed rapid activation of p38, which started at 15 min of the treatment, reached a plateau at 30 -120 min and 175 declined by 4 h. Meanwhile, the p62 mRNA continued to increase 4 -24 h of the treatment 176 duration. Because p38 activation can be induced by reactive oxygen species (ROS), we tested 177 whether oxidative stress plays a role in p62 induction by the rocaglate. However, p62 mRNA 178 induction was unaffected in the presence of ROS scavenger N-acetyl-cysteine (NAC) (Fig.2G) .
179
Comparing the p62-inducing activities of CMLD010536 with natural rocaglates silvestrol and 180 rocaglamide A demonstrated that those compounds had similar activities in this assay, while 181 CMLD010850 did not induce p62 induction (Fig.2H ). This observation is consistent with the 182 importance of translation inhibitory activities of rocaglates in macrophage activation. Notably, 183 another suppressor of cap-dependent translation rapamycin, which is known to inhibit 184 translation via inhibition of mTOR pathway, as well as the known translation elongation inhibitor 185 cycloheximide, both failed to stimulate p62 gene expression, (Fig.2I ). rocaglates on macrophages mimic diverse stressors whose activities converge on a common 201 stress response module -ISR. In contrast to eIF2A kinases, however, the effect of rocaglates is 202 partial and selective that allows for the upregulation of proteins that activate stress adaptation 203 pathways.
205
P38 mediates synergy of rocaglates with low concentrations of IFNγ
207
In the presence of low concentrations of IFNγ, CMLD010536 induces upregulation of 208 IRF1, a key transcription factor in the IFNγ network. The upregulation of the IRF1 gene 209 expression by IFNγ is mediated by the binding of STAT1 homodimers to the gamma-activatable 210 sequence (GAS) in the IRF1 promoter. STAT1 homodimer formation and promoter binding 211 requires STAT1 phosphorylation at the canonical tyrosine-701 by JAK kinases, an event that 212 occurs upon IFNγ binding to its receptor (34, 35). However, CMLD010536 increased neither the 213 promoter binding activity of STAT1, nor its phosphorylation at the canonical tyrosine site (data 214 not shown). There is an emerging evidence that serine phosphorylation of STAT1 by stress-215 activated MAP kinases p38 and JNK may mediate various stress responses (36). Thus, Ser-216 727 phosphorylation of STAT1 accounts for nearly 80% of IFNγ-induced transcriptional 217 activity, but does not mediate STAT1 DNA binding or nuclear translocation (37-39).
218
Therefore, we tested whether MAP kinase(s) mediate the synergistic effect of rocaglate on 219 IRF1 induction.
220
As shown in Fig.3A , treatment of BMDMs with the rocaglate alone suppressed IRF1 221 protein levels. However, in the presence of IFNγ at concentrations as low as 0.05 and 0.1 U/ml,
222
CMLD010536 boosted the levels of IRF1 protein and this effect was abrogated by p38 inhibition.
223
Rocaglate treatment induced p38 phosphorylation in these settings, while low concentrations of 224 IFNγ alone did not ( Fig.3B ). We observed similar effect of the p38 inhibitor on IRF1 mRNA 225 induction ( Fig.3C ), while it had no negative effect on IRF1 mRNA levels induced by increasing concentrations of IFNγ alone (Fig.3D ). In addition, we found that CMLD010536 induced 227 STAT1 Ser727 phosphorylation as early as 15 min which was maintained at least up to 4 h 228 ( Fig. 3E) . Thus, we propose a model where low doses of IFNγ are sufficient to initiate STAT1 229 dimer formation and binding to the IRF1 promoter, while the p38 activation boosts and 230 sustains the IRF1 transcription by enhancing interactions with transcriptional co-activators in 231 a STAT1 Ser-727 dependent manner.
232
To summarize the findings above, we determined that p38 MAPK pathway activation 
254
CMLD010536, silvestrol and rocaglamide A ( Fig.4D ), but not by CMLD010850, which is a less 255 potent translational inhibitor (Fig 1C) . These observations suggested that translation inhibition 256 was necessary to inhibit STAT6 DNA binding activity, but was not due to reduced STAT6 257 protein levels, i.e. it was a regulatory phenomenon.
258
We next sought to determine whether the rocaglate suppressor activity was mediated by 259 stress kinases and found that neither p38 nor JNK inhibitors ( Fig.4E and F The SQSTM1/p62 protein, which is induced by rocaglates in an IFNγ-independent manner, 276 coordinates activation of central stress response pathways: antioxidative defense and 277 autophagy (24, 25, 28-33, 43). Upon oxidative stress, p62 targets KEAP1 protein, an inhibitor of 278 a transcription factor NRF2, for degradation. NRF2 induces the expression of major anti-oxidant 279 genes. We found that several anti-oxidative genes including catalase, TXNIP and HO-1 were 280 upregulated in macrophages treated with 100 nM of CMLD010536 (Fig 5A) . Similar to the 281 induction of p62, this effect was also mediated by p38 MAPK (Fig.5B ). However, ROS were not 282 required for the induction of either p62 or TXNIP by rocaglates, since in both cases ROS 283 scavenger NAC did not reduce their mRNA induction by CMLD010536 ( Fig.2G and 
288
Macrophages pretreated with 30 -100 nM of CMLD010536 for 6 h survived the exposure to 289 toxic concentration of sodium arsenate, as determined by measuring the percentage of dead (PI 290 positive) macrophages after the 18 h exposure (Fig. 5C ).
291
The SQSTM/p62 protein is also a major adaptor protein that mediates selective 292 autophagy and targets intracellular bacteria to LC3-positive autophagosomes(44). In addition to 293 the p62 induction, we have previously reported that the rocaglate treatment stimulates 294 autophagic flux and increases the lipidated form of LC3 associated with autophagosome 295 maturation (16). Therefore, we tested whether rocaglate pretreatment increased autophagy of 
303
These data demonstrate that priming with the rocaglate significantly increased clearance of a 304 vacuolar intracellular bacteria (BCG) by macrophages via autophagy induction.
305
To begin testing effects of rocaglates in vivo, we have chosen a model of acute 306 respiratory challenge with Streptococcus pneumoniae (serotype 3). Alveolar macrophages (AM) 307 play an important role at the early phase of this infection (45, 46) . It is also worth noting that in 308 naïve hosts the AM displays an M2-like phenotype. We wondered whether rocaglate 309 pretreatment could prime macrophages for more efficient control of the acute bacterial infection. 
349
We found that rocaglates potently inhibit ERK phosphorylation, a key activation step in 
360
The canonical eIF4A-dependent translation inhibition by rocaglates may provide an 361 unknown "stress-like" signal that leads to the inhibition of ERK phosphorylation and, thus, to the 362 coordinated downregulation of several anabolic pathways. Yet, another mechanism may be 363 associated with a recently described alternative target of rocaglates -prohibitin. Rocaglates 
386
The biological effects of the rocaglate treatment are not limited to IRF1 induction. They 387 significantly overlap with pleiotropic effects of IFNγ on macrophages, including translation 388 inhibition, autophagy induction and IL-4 suppression ( Supplemental Table 3 ). Importantly,
389
rocaglates mimic yet another, less studied, effect of IFNγ. The anti-inflammatory property of 390 IFNγ has been documented in animal models of chronic inflammation, such as streptococcal 
418
where the cells are exposed to complex, often conflicting environmental signals (Fig.6 ).
419
Channeling macrophage differentiation towards the M1-like phenotype would be 420 especially useful in case of co-infections that cause opposite macrophage polarization 421 programs. For example, by inducing the M2 macrophage polarization, helminth infections may 422 increase susceptibility to mycobacterial infections. Those infections co-exist in endemic regions, 423 such as sub-Saharan Africa and are presumed to contribute to failures of TB vaccination to 424 protect against TB (6). Rocaglates may also substitute for decreased production of IFNγ by T 425 cells in HIV-TB co-infections.
426
We envision that rocaglates may be also useful in chronic non-infectious inflammatory 
440
In asthma, allergic reactions may be associated with chronic bacterial infections.
441
Currently, asthma therapy relies on immune suppression by corticosteroids. However, 442 prolonged treatment with steroids may lead to chronic pulmonary infections caused by 443 opportunistic mycobacteria and fungi that further exacerbate pulmonary pathology(69)). The 
550
The BCG loads were enumerated by CFU plating. 
571
Gel shift assay
572
The nuclear extracts were prepared by Signosis Inc. nuclear extraction kits. Gel shift assays 573 were done with EMSA kits (Signosis Inc). 5 μ g nuclear extracts were incubated with 1× binding 574 buffer and biotin-labeled probe for 30 min at room temperature to form protein/DNA complexes.
575
The samples were then electrophoresed on a 6 % polyacrylamide gel in 0.5 % TBE at 120 V for 576 45 min and then transferred onto a nylon membrane in 0.5 % TBE at 300 mA for 1 h. After 577 transfer and UV cross-linking, the membrane was detected with Streptavidin-HRP.
578
Immunoblotting
579
BMDMs were subjected to treatments specified in the text. 
633
The images were processed using FIJI software and the percentage of co-localization of 
